Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SGD vs WELL vs GMRE vs VTR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SGD
Safe and Green Development Corporation

Real Estate - Development

Real EstateNASDAQ • US
Market Cap$155K
5Y Perf.-99.4%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+129.9%
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-23.0%
VTR
Ventas, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$41.15B
5Y Perf.+84.4%

SGD vs WELL vs GMRE vs VTR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SGD logoSGD
WELL logoWELL
GMRE logoGMRE
VTR logoVTR
IndustryReal Estate - DevelopmentREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$155K$149.25B$94M$41.15B
Revenue (TTM)$5M$11.63B$148M$6.13B
Net Income (TTM)$-14M$1.43B$2M$260M
Gross Margin16.6%39.1%68.8%-4.3%
Operating Margin-186.2%4.4%24.9%13.4%
Forward P/E78.4x595.7x118.0x
Total Debt$10M$21.38B$654M$13.22B
Cash & Equiv.$296K$5.03B$7M$741M

SGD vs WELL vs GMRE vs VTRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SGD
WELL
GMRE
VTR
StockSep 23Feb 26Return
Safe and Green Deve… (SGD)1000.6-99.4%
Welltower Inc. (WELL)100229.9+129.9%
Global Medical REIT… (GMRE)10077.0-23.0%
Ventas, Inc. (VTR)100184.4+84.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SGD vs WELL vs GMRE vs VTR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Safe and Green Development Corporation is the stronger pick specifically for growth and revenue expansion. GMRE and VTR also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
SGD
Safe and Green Development Corporation
The Real Estate Income Play

SGD is the #2 pick in this set and the best alternative if growth is your priority.

  • 27.7% FFO/revenue growth vs GMRE's -1.8%
Best for: growth
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
  • 223.1% 10Y total return vs GMRE's 308.1%
  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
  • Lower P/E (78.4x vs 595.7x)
Best for: growth exposure and long-term compounding
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE is the clearest fit if your priority is income & stability.

  • Dividend streak 5 yrs, beta 0.48, yield 63.5%
  • 63.5% yield, 5-year raise streak, vs WELL's 1.3%, (1 stock pays no dividend)
Best for: income & stability
VTR
Ventas, Inc.
The Real Estate Income Play

VTR is the clearest fit if your priority is defensive.

  • Beta 0.01, yield 2.1%, current ratio 0.96x
  • Beta 0.01 vs SGD's 1.69, lower leverage
Best for: defensive
See the full category breakdown
CategoryWinnerWhy
GrowthSGD logoSGD27.7% FFO/revenue growth vs GMRE's -1.8%
ValueWELL logoWELLLower P/E (78.4x vs 595.7x)
Quality / MarginsWELL logoWELL12.3% margin vs SGD's -277.3%
Stability / SafetyVTR logoVTRBeta 0.01 vs SGD's 1.69, lower leverage
DividendsGMRE logoGMRE63.5% yield, 5-year raise streak, vs WELL's 1.3%, (1 stock pays no dividend)
Momentum (1Y)WELL logoWELL+42.7% vs SGD's -80.4%
Efficiency (ROA)WELL logoWELL2.3% ROA vs SGD's -35.9%, ROIC 0.5% vs -50.6%

SGD vs WELL vs GMRE vs VTR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SGDSafe and Green Development Corporation

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M
GMREGlobal Medical REIT Inc.

Segment breakdown not available.

VTRVentas, Inc.
FY 2025
Senior Living Operations
74.0%$4.3B
Outpatient Medical And Research Portfolio
15.5%$898M
Triple Net Leased Properties
10.4%$602M

SGD vs WELL vs GMRE vs VTR — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGSGD

Income & Cash Flow (Last 12 Months)

Evenly matched — SGD and GMRE each lead in 2 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 2339.8x SGD's $5M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to SGD's -2.8%. On growth, SGD holds the edge at +42.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
RevenueTrailing 12 months$5M$11.6B$148M$6.1B
EBITDAEarnings before interest/tax-$9M$2.8B$95M$2.3B
Net IncomeAfter-tax profit-$14M$1.4B$2M$260M
Free Cash FlowCash after capex-$3M$2.5B$19M$1.4B
Gross MarginGross profit ÷ Revenue+16.6%+39.1%+68.8%-4.3%
Operating MarginEBIT ÷ Revenue-186.2%+4.4%+24.9%+13.4%
Net MarginNet income ÷ Revenue-2.8%+12.3%+1.7%+4.2%
FCF MarginFCF ÷ Revenue-52.9%+21.9%+12.6%+22.4%
Rev. Growth (YoY)Latest quarter vs prior year+42.3%+40.3%+18.7%+22.0%
EPS Growth (YoY)Latest quarter vs prior year+57.1%+22.5%-166.2%0.0%
Evenly matched — SGD and GMRE each lead in 2 of 6 comparable metrics.

Valuation Metrics

GMRE leads this category, winning 3 of 6 comparable metrics.

At 115.3x trailing earnings, GMRE trades at a 28% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than WELL's 66.4x.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
Market CapShares × price$155,445$149.2B$94M$41.1B
Enterprise ValueMkt cap + debt − cash$10M$165.6B$741M$53.6B
Trailing P/EPrice ÷ TTM EPS-0.02x153.25x115.29x160.26x
Forward P/EPrice ÷ next-FY EPS est.78.42x595.67x118.01x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.40x8.35x24.31x
Price / SalesMarket cap ÷ Revenue0.75x13.99x0.68x7.05x
Price / BookPrice ÷ Book value/share0.18x3.35x0.17x3.18x
Price / FCFMarket cap ÷ FCF52.41x31.25x
GMRE leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 4 of 9 comparable metrics.

WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-7 for SGD. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to SGD's 11.95x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs GMRE's 4/9, reflecting strong financial health.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
ROE (TTM)Return on equity-7.0%+3.5%+0.5%+2.1%
ROA (TTM)Return on assets-35.9%+2.3%+0.2%+1.0%
ROICReturn on invested capital-50.6%+0.5%+2.0%+2.5%
ROCEReturn on capital employed-3.1%+0.6%+5.3%+3.2%
Piotroski ScoreFundamental quality 0–95746
Debt / EquityFinancial leverage11.95x0.49x1.18x1.05x
Net DebtTotal debt minus cash$10M$16.3B$647M$12.5B
Cash & Equiv.Liquid assets$296,202$5.0B$7M$741M
Total DebtShort + long-term debt$10M$21.4B$654M$13.2B
Interest CoverageEBIT ÷ Interest expense-1.89x0.26x1.14x1.40x
WELL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $13 for SGD. Over the past 12 months, WELL leads with a +42.7% total return vs SGD's -80.4%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs SGD's -89.1% — a key indicator of consistent wealth creation.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
YTD ReturnYear-to-date-14.9%+14.3%+6.9%+12.6%
1-Year ReturnPast 12 months-80.4%+42.7%+0.1%+33.9%
3-Year ReturnCumulative with dividends-99.9%+189.5%+5.6%+94.2%
5-Year ReturnCumulative with dividends-99.9%+202.3%-21.4%+74.8%
10-Year ReturnCumulative with dividends-99.9%+223.1%+308.1%+65.0%
CAGR (3Y)Annualised 3-year return-89.1%+42.5%+1.8%+24.8%
WELL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

VTR leads this category, winning 2 of 2 comparable metrics.

VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than SGD's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs SGD's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
Beta (5Y)Sensitivity to S&P 5001.69x0.13x0.48x0.01x
52-Week HighHighest price in past year$2.36$219.59$39.93$88.50
52-Week LowLowest price in past year$0.11$142.65$29.05$61.76
% of 52W HighCurrent price vs 52-week peak+6.9%+97.0%+89.5%+97.8%
RSI (14)Momentum oscillator 0–10040.060.252.756.2
Avg Volume (50D)Average daily shares traded02.6M130K3.4M
VTR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

GMRE leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: WELL as "Buy", GMRE as "Buy", VTR as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 4.9% for VTR (target: $91). For income investors, GMRE offers the higher dividend yield at 63.51% vs WELL's 1.30%.

MetricSGD logoSGDSafe and Green De…WELL logoWELLWelltower Inc.GMRE logoGMREGlobal Medical RE…VTR logoVTRVentas, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$226.50$40.00$90.80
# AnalystsCovering analysts342232
Dividend YieldAnnual dividend ÷ price+1.3%+63.5%+2.1%
Dividend StreakConsecutive years of raises251
Dividend / ShareAnnual DPS$2.76$22.70$1.86
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%
GMRE leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

GMRE leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). WELL leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.

Best OverallWelltower Inc. (WELL)Leads 2 of 6 categories
Loading custom metrics...

SGD vs WELL vs GMRE vs VTR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SGD or WELL or GMRE or VTR a better buy right now?

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SGD or WELL or GMRE or VTR?

On trailing P/E, Global Medical REIT Inc.

(GMRE) is the cheapest at 115. 3x versus Ventas, Inc. at 160. 3x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SGD or WELL or GMRE or VTR?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -99. 9% for Safe and Green Development Corporation (SGD). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus SGD's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SGD or WELL or GMRE or VTR?

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Safe and Green Development Corporation's 1. 69β — meaning SGD is approximately 17692% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 12% for Safe and Green Development Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — SGD or WELL or GMRE or VTR?

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -21. 2% for Safe and Green Development Corporation. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SGD or WELL or GMRE or VTR?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus -42. 9% for Safe and Green Development Corporation — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus -31. 6% for SGD. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SGD or WELL or GMRE or VTR more undervalued right now?

On forward earnings alone, Welltower Inc.

(WELL) trades at 78. 4x forward P/E versus 595. 7x for Global Medical REIT Inc. — 517. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — SGD or WELL or GMRE or VTR?

In this comparison, GMRE (63.

5% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. SGD does not pay a meaningful dividend and should not be held primarily for income.

09

Is SGD or WELL or GMRE or VTR better for a retirement portfolio?

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Safe and Green Development Corporation (SGD) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTR: +65. 0%, SGD: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SGD and WELL and GMRE and VTR?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SGD is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; GMRE is a small-cap income-oriented stock; VTR is a mid-cap high-growth stock. WELL, GMRE, VTR pay a dividend while SGD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SGD

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $20B
  • Revenue Growth > 2114%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Stocks Like

VTR

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SGD and WELL and GMRE and VTR on the metrics below

Revenue Growth>
%
(SGD: 4229.2% · WELL: 40.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.